Dow Up 0.11% Nasdaq Up 0.50%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.12 0.00(0.00%) Aug 29, 4:00PM EDT
|After Hours : 4.15 Up 0.03 (0.73%) Aug 29, 7:59PM EDT
Prev Close:4.12
Open:4.14
Bid:4.15 x 500
Ask:4.29 x 300
1y Target Est:7.06
Beta:-2.28
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.10 - 4.31
52wk Range:4.05 - 7.97
Volume:4,838,576
Avg Vol (3m):4,937,600
Market Cap:905.72M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNA 0.00%905.72M
GSKUp 0.47%117.94B
OREXDown 0.52%698.44M
RHHBYDown 0.14%248.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback